×
Hero Background

Carcinoembryonic Antigen Companies

ID: MRFR/Pharma/0288-HCR
81 Pages
Rahul Gotadki
October 2025

Carcinoembryonic antigen (CEA) companies focus on developing diagnostic tests and technologies for detecting CEA, a protein associated with certain cancers, particularly colorectal cancer. These companies contribute to oncology by providing assays and tools that aid in cancer screening, monitoring, and treatment decision-making.

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Carcinoembryonic Antigen Market Research Report - Global Forecast till 2035 Infographic
Summary Table of Contents Segmentation Download PDF

Top Industry Leaders in the Carcinoembryonic Antigen Market

Carcinoembryonic antigen (CEA) companies

 


Latest Carcinoembryonic antigen Companies Updates:


Dec 2024


Abbott Laboratories Launched their ARCHITECT® i1000SR immunoassay analyzer featuring a highly sensitive CEA assay, offering rapid and accurate detection of low-level CEA levels for early cancer detection.Partnered with healthcare institutions to implement their automated and efficient CEA testing solutions for improved patient care.


Roche Holding AG Expanded their cobas® elecsys immunoassay platform with a new, highly specific CEA test, minimizing interference from other factors and providing reliable results for cancer diagnosis and monitoring.Focused on developing integrated and automated laboratory solutions for efficient and seamless CEA testing workflows.


Siemens Healthineers Introduced their Atellica® IM immunoassay analyzer featuring a multi-parameter test cartridge including CEA, enabling simultaneous testing of various tumor markers for comprehensive cancer diagnosis.Emphasized their commitment to providing clinicians with comprehensive diagnostic tools for accurate cancer detection and management.


Bio-Rad Laboratories Developed new point-of-care CEA testing kits offering rapid and convenient testing options for clinicians and patients, potentially facilitating early cancer screening in resource-limited settings.Collaborated with public health organizations to improve access to CEA testing in underserved communities.


GenScript CorporationLaunched their ELISA-based CEA testing kits with high sensitivity and specificity, catering to research laboratories and diagnostic centers for accurate CEA level determination.Focused on providing affordable and reliable tools for CEA research and clinical applications.


List of Carcinoembryonic antigen Key companies in the market



  • Lee BioSolutions

  • F. Hoffmann-La Roche

  • Quest Diagnostics Incorporated

  • Genway Biotech

  • RayBiotech

  • Merck KGaA

  • Abcam plc

  • Boster Biological Technology

  • Creative Diagnostics

  • Laboratory Corporation of America Holdings